Approved Drugs for Dermatology/Plastic Surgery

Drugs Approved in 2008

Drugs Approved in 2007

• Altabax (retapamulin); For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes; Glaxo; Approved April 2007
• Extina (ketoconazole); For the treatment of seborrheic dermatitis; Stiefel; Approved June 2007
• Xyzal (levocetirizine dihydrochloride); For the treatment of seasonal and perennial allergic rhinitis and urticaria; UCB Inc.; Approved May 2007

Drugs Approved in 2006

• Desonate (desonide); For the treatment of atopic dermatitis; Dow Pharm; Approved October 2006
• Verdeso (desonide); For the treatment of atopic dermatitis; Connetics; Approved September 2006

Drugs Approved in 2005

Drugs Approved in 2004

Drugs Approved in 2003

• Amevive (alefacept); For moderate to severe chronic plaque psoriasis.; Biogen; Approved January 2003
• Finacea (azelaic acid) Gel, 15%; Gel formulation for the treatment of rosacea.; Berlex Laboratories; January 2003

Drugs Approved in 2002

• Botox Cosmetic (botulinum toxin type A); For the temporary improvement in the appearance of glabellar lines (brow furrow); Allergan; Approved April 2002

Drugs Approved in 2001

• Elidel; Topical cream for the treatment of atopic dermatitis; Novartis; Approved December 2001
• Estrostep (ethinyl estradiol and norethindrone acetate); For the treatment of moderate acne vulgaris; Pfizer; Approved July 2001
• Finevin; Topical cream for the treatment of mild to moderate inflammatory acne vulgaris; Berlex Laboratories; Approved May 2001
• Invanz; Once-daily injectable treatment for bacterial infections; Merck; Approved November 2001
• Lamisil Solution, 1%; Topical treatment for tinea (pityriasis) versicolor, althete's foot, jock itch, and ringworm; Novartis; Approved March 2001

Drugs Approved in 2000

• Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel); For the topical treatment of acne vulgaris; Dermik Laboratories; Approved November 2000
• Cefazolin and Dextrose USP; Respiratory tract infections; B Braun Medical; Approved July 2000
• Chloraprep (chlorhexidine gluconate); For use as a patient preoperative skin preparation; MEDI FLEX HOSP PRODUCTS; Approved July 2000
• Clindamycin phosphate topical gel; For once a day treatment of acne vulgaris; Target Research Associates; Approved November 2000
• Lamisil (terbinafine hydrochloride) Solution, 1%; For the treatment of athlete's foot, jock itch and ringworm; Novartis; Approved March 2000
• Protopic (tacrolimus) ointment; For short-term and intermittent long-term treatment of moderate to severe atopic dermatitis; Fujisawa Healthcare; Approved December 2000
• Skin Exposure Reduction Paste Against Chemical Warfare Agents (SERPACWA); To reduce absorption of chemical warfare agents through the skin; U.S. Army Medical Research, Material Command; Approved February 2000

Drugs Approved in 1999

• Lamisil/terbinafine Dermgel, 1%; Treatment for tinea pedis (athlete's foot); Novartis; Approved March 1999
• Luxiq (betamethasone valerate) Foam; Treatment for dermatoses of scalp; Connetics Corporation; Approved June 1999

Drugs Approved in 1998

• Avita Gel; Treatment for acne; Penederm; Approved February 1998
• Dynabac; Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections); Sanofi Pharmaceuticals; Approved March 1998
• Lustra; Treatment for ultraviolet-induced skin discolorations; Medicis Pharmaceutical; Approved January 1998
• MetroLotion; Treatment of inflammatory papules and pustules of rosacea; Galderma Laboratories; Approved November 1998
• Noritate; Treatment for rosacea; Dermik Laboratories; Approved January 1998
• Salagen Tablets; Treatment for Sjogren's Syndrome; MGI Pharma; Approved February 1998
• Sulfamylon; Treatment used to control bacterial infections on excised burn wounds; Mylan Laboratories; Approved June 1998
• Thalomid; Treatment for moderate to severe erythema nodosum leprosum (ENL); Celgene; Approved July 1998

Drugs Approved in 1997

• Avita; Treatment for acne; Penederm; Approved January 1997
• Bactroban Cream; Treatment for secondarily infected traumatic skin lesions; SmithKline Beecham; Approved December 1997
• Clindamycin Phosphate Topical Solution USP 1%; Generic equivalent of CLEOCIN Topical Solution 1%; Morton Grove Pharmaceuticals; Approved July 1997
• Condylox Gel 0.5% (pokofilox); Treatment for external genital and perianal warts; Oclassen Pharmaceuticals; Approved March 1997
• Dermagraft-TC; Treatment for partial-thickness and severe burns; Advanced Tissue Sciences; Approved October 1997
• Klaron (sodium sulfacet amide lotion ) Lotion, 10%; Treatment for adult acne; Dermik Laboratories; Approved February 1997
• Mentax; Treatment for athlete's foot; Penederm; Approved December 1997
• Mentax; Treatment for tinea corporis (ringworm) and tinea cruris (groin fungus); Penederm; Approved January 1997
• Minoxidil Topical Solution 2% for Women; Generic equivalent of Rogaine; Alpharma; Approved April 1997
• Omnicef; Treatment against various bacterias; Warner-Lambert; Approved December 1997
• Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol); Treatment for acne in women seeking contraception; Ortho Pharmaceutical; Approved January 1997
• Propecia; Treatment for male baldness; Merck; Approved December 1997
• REGRANEX (becaplermin) Gel; Treatment for diabetic foot ulcers; R.W. Johnson; Approved December 1997
• Retin-A Micro (tretinoin gel) microsphere, 0.1%; Treatment for acne; Advanced Polymer Systems; Approved February 1997
• Tazorac topical gel; Treatment for Psoriasis, Acne Vulgaris; Allergan; Approved June 1997

Drugs Approved in 1996

• Differin (adapalene gel) Gel, 0.1%; Treatment for acne; Galderma Laboratories; Approved June 1996
• Iamin; Gel wound dressing; ProCyte; Approved February 1996
• Iontocaine; Needle-free anesthetic; Iomed; Approved May 1996
• IvyBlock; Treatment for poison ivy, poison oak, and poison sumac; EnviroDerm Pharmaceuticals; Approved September 1996
• Mentax (1% butenafine HCI cream); Treatment for athlete's foot; Penederm; Approved April 1996

Drugs Approved in 1995

• Renova (tretinoin emollient cream); Treatment for facial wrinkles, brown spots, and surface roughness associated with chronic sun exposure; Johnson & Johnson; Approved December 1995